Seroprevalence of SARS-CoV-2 among blood donors: A practical serosurveillance tool for COVID-19 - 01/05/22
Doi : 10.1016/j.tracli.2021.11.005
N. Bansal a, ⁎ 
, M. Raturi b, Y. Bansal c
, M. Raturi b, Y. Bansal c a Department of Transfusion Medicine, VCSG Government Institute of Medical Science and Research, Srinagar, Uttarakhand, India
b Department of Immunohematology and Blood Transfusion, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, Jolly Grant, Dehradun, Uttarakhand, India
c Department of Microbiology, VCSG Government Institute of Medical Science and Research, Srinagar, Uttarakhand, India
⁎Corresponding author at: Department of Transfusion Medicine, VCSG Government Institute of Medical Science and Research, Srinagar, Uttarakhand, India.Department of Transfusion Medicine, VCSG Government Institute of Medical Science and Research, SrinagarUttarakhandIndia
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Le texte complet de cet article est disponible en PDF.
Plan
© 2021
Société française de transfusion sanguine (SFTS). Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 29 - N° 2
P. 182-183 - mai 2022 Retour au numéro
Article précédent
- Significant decrease in the transfusion rates during the COVID-19 pandemic in the North East of Iran
- S. Boroumand-Noughabi, A. Rahmati, N. Morovatdar, M. Keramati
- COVID-19convalescent plasma use in the oncology and geriatric patients: Ethical aspects in transfusion medicine
- N. Bansal, M. Raturi, Y. Bansal
Bienvenue sur EM-consulte, la référence des professionnels de santé.